Evogene (NASDAQ:EVGN) Now Covered by StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN) in a report released on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock.

Separately, Lake Street Capital lowered their target price on Evogene from $30.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, August 23rd.

Evogene Price Performance

Shares of NASDAQ:EVGN opened at $3.00 on Friday. Evogene has a 1 year low of $2.72 and a 1 year high of $10.40. The firm has a market capitalization of $123.65 million, a PE ratio of -6.52 and a beta of 1.40. The firm’s 50-day moving average is $4.30 and its two-hundred day moving average is $6.22.

Evogene (NASDAQ:EVGN) last issued its quarterly earnings data on Thursday, August 22nd. The biotechnology company reported ($1.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.94). Evogene had a negative net margin of 210.26% and a negative return on equity of 72.33%. The firm had revenue of $0.91 million during the quarter.

Institutional Trading of Evogene

A hedge fund recently raised its stake in Evogene stock. BNP Paribas Financial Markets raised its position in Evogene Ltd. (NASDAQ:EVGN) by 30.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,400 shares of the biotechnology company’s stock after purchasing an additional 21,500 shares during the quarter. BNP Paribas Financial Markets owned 0.22% of Evogene worth $69,000 at the end of the most recent quarter. 10.40% of the stock is owned by institutional investors.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.